Medication Considerations

The findings from this Issue Brief reveal notable gaps in integrated SUD and mental health services, inpatient and residential care capacity, and use of medications for SUD treatment, with substantial variation across states and territories.

The article reviews the role that telehealth can play in providing medications for opioid use disorder (MOUD) treatment.

This article reviews medication for opioid use disorder (MOUD) treatments in the United States from data pulled from the 2022 National Survey on Drug Use and Health.

This Advisory outlines how healthcare providers (i.e., obstetrician-gynecologists [OB-GYNs], primary care physicians, and other professionals who treat pregnant people) can take an active role in supporting the health of pregnant individuals who have OUD and their babies.

This Quick Take outlines the legal and policy efforts that have led to an increase in availability and stresses the importance of continued advocacy efforts to further expand MOUD availability in jails and prisons and in the community.

This NIDA web page includes facts and figures on addressing substance use disorders in the prison population.

This NIDA web page includes facts and figures on prescription opioids.

This two-page pocket guide includes facts and a checklist for all practitioners seeking to prescribe buprenorphine.

This quick start guide includes facts and a checklist for all practitioners seeking to prescribe buprenorphine.

This toolkit provides guidance and information to hospitals and health systems on how they can partner with patients, clinicians and communities to address the opioid epidemic.